Patent · US Active

Antagonistic DR3 ligands

US8765130B2 · kind B2 · utility

0Cited by
0References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 23, 2013
Grant dateJul 1, 2014
Priority date
Expiry dateAug 23, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to treatment of inflammatory diseases. In particular, the present invention relates to antagonistic DR3 ligands useful for treating inflammatory diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.